Kanwaljit Singh

Kanwaljit Singh, MD, MPH, MBA, currently serves as the Executive Director of the Innovative Neurotherapeutics Consortium and Director of Pediatric Programs at the Critical Path Institute since 2020. Prior to this role, Kanwaljit Singh was an Instructor in Pediatric Neurology at the University of Massachusetts Medical School from 2013 to 2019, where responsibilities included conducting and managing investigator-initiated phase 2 clinical trials and observational studies related to autism spectrum disorder and other pediatric neurological conditions. Academic credentials include an Executive MBA from UCLA Anderson School of Management, a Master of Public Health from Harvard University, and a Bachelor of Medicine, Bachelor of Surgery degree from Government Medical College & Hospital, Chandigarh.